CB-103
CB-103 Uses, Dosage, Side Effects, Food Interaction and all others data.
CB-103 is under investigation in clinical trial NCT03422679 (Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies).
| Trade Name | CB-103 |
| Generic | CB-103 |
| Type | |
| Formula | C15H18N2O |
| Weight | Average: 242.322 Monoisotopic: 242.141913208 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here CB-103
